By Jeff Overley ( May 26, 2015, 3:16 PM EDT) -- A brief section in the fast-evolving 21st Century Cures Act would modestly loosen U.S. Food and Drug Administration restrictions on drugmaker claims of cost-effectiveness but will only provide significant cover from enforcement actions if lawmakers get bolder with the legislative language, experts say....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.